Co-structure Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform complexed with brain penetrant inhibitors

Co-structure Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform complexed with brain penetrant inhibitors Descriptor: (2M)-7-[(3R)-3-methylmorpholin-4-yl]-5-[(3S)-3-methylmorpholin-4-yl]-2-(1H-pyrazol-3-yl)-3H-imidazo[4,5-b]pyridine, Phosphatidylinositol 3-kinase regulatory subunit alpha, Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform Authors: Knapp, M.S, Elling, R.A, Tang, J. Deposit date: 2023-04-03 Release date: 2023-07-19 Last modified: 2024-05-22 Method: X-RAY DIFFRACTION (3.1 Å) Cite: Identification of Brain-Penetrant ATP-Competitive mTOR Inhibitors for CNS Syndromes. J.Med.Chem., 66, 2023

共晶复合物结构：结合脑穿透性抑制剂的磷脂酰肌醇4,5-二磷酸3-激酶催化亚基α亚型（Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform）。
描述组分：(2M)-7-[(3R)-3-甲基吗啉-4-基]-5-[(3S)-3-甲基吗啉-4-基]-2-(1H-吡唑-3-基)-3H-咪唑并[4,5-b]吡啶、磷脂酰肌醇3-激酶调节亚基α（Phosphatidylinositol 3-kinase regulatory subunit alpha）、磷脂酰肌醇4,5-二磷酸3-激酶催化亚基α亚型（Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform）
作者：Knapp, M.S、Elling, R.A、Tang, J.
存档日期：2023-04-03
发布日期：2023-07-19
最后修改日期：2024-05-22
实验方法：X射线衍射（X-RAY DIFFRACTION，分辨率3.1 Å）
引用文献：《用于中枢神经系统综合征的脑穿透性ATP竞争性哺乳动物雷帕霉素靶蛋白（mTOR）抑制剂的鉴定》，《药物化学杂志》（J.Med.Chem.），第66卷，2023年